http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008118785-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dfb797de1183a30bf3fc947049808878
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6f1c879e3c6a92035fcc6401df5399f6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_501c8cc3f8a62b8f64f3a5b53f1230f1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_774427b515300f78834c4cc16751cc2f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2dbc91b9f1eb1f3de32e5be204f0c410
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-42
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135
filingDate 2008-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be0eb24c5913769121f55095099a319c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_49871ff46f564ab9b17acfb73a8b8559
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b9810c9cfdef5457d1bbbd12c904cf0c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b016ebfb3c37017e746488aae19123f7
publicationDate 2008-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2008118785-A3
titleOfInvention Methods for treating depression using immediate-impact treatments and d-cycloserine
abstract Methods are provided for treating depression in humans. The methods comprise administering D-cycloserine to a subject and administering an immediate-impact depression treatment. Exemplary immediate-impact treatments for depression include administration of ketamine, as well as non-pharmacologic treatments such as electroconvulsive shock therapy.
priorityDate 2007-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005222270-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9952519-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3821
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406322
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406323
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID644025

Total number of triples: 26.